Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2007438 | 1.00 | MAPT (0.49) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL16135282 | 1.00 | MAPT (0.49) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL10605933 | 1.00 | MAPT (0.49) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL16135275 | 1.00 | MAPT (0.49) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL15688422 | 1.00 | MAPT (0.49) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL23345517 | 1.00 | MAPT (0.49) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL6434868 | 0.98 | MAPT (0.50) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL6434876 | 0.98 | MAPT (0.50) | MAPTHTTALDH1A1LMNAGAA | |
| SCHEMBL16135276 | 0.95 | MAPT (0.46) | MAPTHTTALDH1A1LMNAPTGS1 | |
| Thiophene SCHEMBL4955558 | 0.94 | MAPT (0.45) | MAPTHTTALDH1A1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3439002-A1 | DYE SOLUTION FOR PHOTOELECTRIC CONVERSION ELEMENT, PREPARATION KIT FOR DYE SOLUTION, AND MANUFACTURING METHOD FOR PHOTOELECTRIC CONVERSION ELEMENT | Fujifilm Corporation (JP) | 2019-02-06 | — | — | EP | disclosed |
| US-7960571-B2 | Silicon-based cross-coupling reagent and production method of organic compound using the same | KYOTO UNIVERSITY (JP) | 2011-06-14 | — | — | US | disclosed |
| US-20090069577-A1 | Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same | KYOTO UNIVERSITY (JP) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069577-A1 | Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same | DNMT1, TET3, CTCF | MAPT 3897/4885HTT 2563/4885ALDH1A1 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.